Literature DB >> 12963755

Cerebrospinal fluid pterins and folates in Aicardi-Goutières syndrome: a new phenotype.

N Blau1, L Bonafé, I Krägeloh-Mann, B Thöny, L Kierat, M Häusler, V Ramaekers.   

Abstract

OBJECTIVE: To describe three unrelated children with a distinctive variant of Aicardi-Goutières syndrome (AGS) characterized by microcephaly, severe mental and motor retardation, dyskinesia or spasticity, and occasional seizures.
RESULTS: Neuroimaging showed bilateral calcification of basal ganglia and white matter. CSF glucose, protein, cell count, and interferon alpha were normal. Abnormal CSF findings included extremely high neopterin (293 to 814 nmol/L; normal 12 to 30 nmol/L) and biopterin (226 to 416 nmol/L; normal 15 to 40 nmol/L) combined with lowered 5-methyltetrahydrofolate (23 to 48 nmol/L; normal 64 to 182 nmol/L) concentrations in two patients. The absence of pleocytosis and normal CSF interferon alpha was a characteristic finding compared to the classic AGS syndrome. Genetic and enzymatic tests excluded disorders of tetrahydrobiopterin metabolism, including mutation analysis of GTP cyclohydrolase feed-back regulatory protein. CSF investigations in three patients with classic AGS also showed increased pterins and partially lowered folate levels.
CONCLUSIONS: Intrathecal overproduction of pterins is the first biochemical abnormality identified in patients with AGS variants. Long-term substitution with folinic acid (2-4 mg/kg/day) resulted in substantial clinical recovery with normalization of CSF folates and pterins in one patient and clinical improvement in another. The underlying defect remains unknown.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963755     DOI: 10.1212/01.wnl.0000082726.08631.e7

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  Aicardi-Goutières syndrome is caused by IFIH1 mutations.

Authors:  Hirotsugu Oda; Kenji Nakagawa; Junya Abe; Tomonari Awaya; Masahide Funabiki; Atsushi Hijikata; Ryuta Nishikomori; Makoto Funatsuka; Yusei Ohshima; Yuji Sugawara; Takahiro Yasumi; Hiroki Kato; Tsuyoshi Shirai; Osamu Ohara; Takashi Fujita; Toshio Heike
Journal:  Am J Hum Genet       Date:  2014-07-03       Impact factor: 11.025

2.  Regression of white matter hypodensities with age in Aicardi-Goutierés syndrome: a case report.

Authors:  Sanjeev V Kothare; Sona A Pungavkar; Deepak P Patkar; Nisha I Sainani; Martand H Naik; Sameeer Gadani
Journal:  Childs Nerv Syst       Date:  2006-06-27       Impact factor: 1.475

3.  Aicardi-Goutières Syndrome.

Authors:  Rashid Merchant; Mitusha Verma; Ami Shah; Shilpa Kulkarni; Anil Jalan
Journal:  Indian J Pediatr       Date:  2016-04-18       Impact factor: 1.967

Review 4.  Monoamine neurotransmitter disorders--clinical advances and future perspectives.

Authors:  Joanne Ng; Apostolos Papandreou; Simon J Heales; Manju A Kurian
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

5.  CSF concentrations of 5-methyltetrahydrofolate in a cohort of young children with autism.

Authors:  John Shoffner; Barbara Trommer; Audrey Thurm; Cristan Farmer; William A Langley; Laura Soskey; Aldeboran N Rodriguez; Precilla D'Souza; Sarah J Spence; Keith Hyland; Susan E Swedo
Journal:  Neurology       Date:  2016-05-13       Impact factor: 9.910

6.  Progressive ataxia and myoclonic epilepsy in a patient with a homozygous mutation in the FOLR1 gene.

Authors:  Belén Pérez-Dueñas; Claudio Toma; Aida Ormazábal; Jordi Muchart; Francesc Sanmartí; Georgina Bombau; Mercedes Serrano; Angels García-Cazorla; Bru Cormand; Rafael Artuch
Journal:  J Inherit Metab Dis       Date:  2010-09-21       Impact factor: 4.982

Review 7.  Tools for diagnosis of leukodystrophies and other disorders presenting with white matter disease.

Authors:  Adeline Vanderver
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

8.  Progressive encephalopathy in a child with cerebral folate deficiency syndrome.

Authors:  Joshua L Bonkowsky; Vincent T Ramaekers; Edward V Quadros; Michael Lloyd
Journal:  J Child Neurol       Date:  2008-10-14       Impact factor: 1.987

9.  Functional regulation of P-glycoprotein at the blood-brain barrier in proton-coupled folate transporter (PCFT) mutant mice.

Authors:  Xueqian Wang; Robert M Cabrera; Yue Li; David S Miller; Richard H Finnell
Journal:  FASEB J       Date:  2012-12-04       Impact factor: 5.191

10.  Brief report: autistic symptoms, developmental regression, mental retardation, epilepsy, and dyskinesias in CNS folate deficiency.

Authors:  Paolo Moretti; Sarika U Peters; Daniela Del Gaudio; Trilochan Sahoo; Keith Hyland; Teodoro Bottiglieri; Robert J Hopkin; Elizabeth Peach; Sang Hee Min; David Goldman; Benjamin Roa; Carlos A Bacino; Fernando Scaglia
Journal:  J Autism Dev Disord       Date:  2007-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.